{
  "trial_id": "NCT03361423",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "will be individually and randomly assigned to either treatment group or control group.",
      "label": "met"
    },
    {
      "criterion": "sham control, electrical pulses of similar width and intensity, but much lower frequency compared to the active device will be administered.",
      "label": "met"
    },
    {
      "criterion": "st visit - screening, enrollment and training on the application in diary mode",
      "label": "met"
    },
    {
      "criterion": "Stage 1 - Roll in phase The Roll-in is a period of 15 - 30 days in which at least two (2) and no more of eight (8) migraine attacks has been occurred.",
      "label": "unknown"
    },
    {
      "criterion": "nd visit Following the Roll-in phase, the participants will arrive to the clinic and their compliance to the study procedures and eligibility to continue to the next phase will assessed.",
      "label": "met"
    },
    {
      "criterion": "Participant will be randomized into one of the two study group (Active or Sham device)",
      "label": "met"
    },
    {
      "criterion": "Participant will be trained on the device, the application (in diary and treatment modes), the treatment procedures and the key elements critical for the success of the study",
      "label": "met"
    },
    {
      "criterion": "Stage 2 - Parallel arms, double- blind treatment phase. Participants will be instructed to activate the device at onset of a qualifying migraine attack and manually adjust stimulation intensity to a level within the pre-defined range, where it is well perceived but not painful.",
      "label": "unknown"
    },
    {
      "criterion": "Via the smartphone application, each participant will be asked to rate his/her migraine pain",
      "label": "met"
    },
    {
      "criterion": "Apply the Nerivio Migra as soon as possible following the onset of the migraine symptoms and NO LATER than 60 min from onset",
      "label": "unknown"
    },
    {
      "criterion": "Refrain from taking any rescue medication 2 hours following the start of treatment.",
      "label": "met"
    },
    {
      "criterion": "Perform the treatment for a period of at least 30 minutes (recommended treatment time is 45 minutes).",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subject has other significant pain, medical or psychologic problems that in the opinion of the investigator may confound the study assessments",
      "label": "not_met"
    },
    {
      "criterion": "Subject has an implanted electrical and/or neurostimulator device (e.g. cardiac pacemaker or defibrillator, vagus nerve neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator cochlear implant, Sphenopalatine ganglion stimulator or Occipital nerve stimulator).",
      "label": "unknown"
    },
    {
      "criterion": "Subject has known uncontrolled epilepsy.",
      "label": "not_met"
    },
    {
      "criterion": "Any use of Cannabis including medical use.",
      "label": "not_met"
    },
    {
      "criterion": "Subject has >10 headache days per month.",
      "label": "unknown"
    },
    {
      "criterion": "Subject has undergone nerve block (occipital or other) in the head or neck within the last 2 weeks.",
      "label": "not_met"
    },
    {
      "criterion": "Subject is participating in any other clinical study.",
      "label": "unknown"
    },
    {
      "criterion": "The subject does not have the basic cognitive and motor skills needed to operate a smartphone.",
      "label": "not_met"
    }
  ],
  "notes": "Patient has history of recurrent bilateral headache, diagnosed with migraine headache. She is under treatment.",
  "_meta": {
    "topic_id": "35",
    "trial_id": "NCT03361423",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}